Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Neeb

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
The Journal of Headache and Pain|January 1, 2022
Deterioration of headache impact and health-related quality of life in migraine patients after cessation of preventive treatment with CGRP(-receptor) antibodiesMaria Terhart, Jasper Mecklenburg, Lars Neeb, et al.
Journal of Medical Internet Research|November 12, 2021
Patients' and Health Care Workers' Perception of Migraine Images on the Internet: Cross-sectional Survey StudyBianca Raffaelli, Pia Kull, Jasper Mecklenburg, et al.
The Journal of Headache and Pain|June 26, 2015
Two TRPV1 receptor antagonists are effective in two different experimental models of migraineJannis E Meents, Jan Hoffmann, Sandra R Chaplan, et al.
The Journal of Headache and Pain|June 23, 2021
Primary headaches during the COVID-19 lockdown in Germany: analysis of data from 2325 patients using an electronic headache diaryBianca Raffaelli, Jasper Mecklenburg, Simon Scholler, et al.
The Journal of Headache and Pain|March 30, 2022
Resumption of migraine preventive treatment with CGRP(-receptor) antibodies after a 3-month drug holiday: a real-world experienceBianca Raffaelli, Maria Terhart, Jasper Mecklenburg, et al.
Pain Medicine (Malden, Mass.)|March 7, 2023
Transcranial direct current stimulation to reduce chronic pelvic pain in endometriosis: phase II randomized controlled clinical trialSylvia Mechsner, Jackie Grünert, Jakob Johann Wiese, et al.
Schmerz (Berlin, Germany)|February 13, 2025
[The headache questionnaire of the German Migraine and Headache Society (DMKG) : A new tool to improve headache care]Ruth Ruscheweyh, Charly Gaul, Thomas Dresler, et al.
Schmerz (Berlin, Germany)|September 11, 2025
[Migraine patients treated with CGRP(R) antibodies : Are they different from patients treated with nonspecific oral prophylaxis? Analysis from the DMKG headache registry]Ruth Ruscheweyh, Gudrun Goßrau, Tim Patrick Jürgens, et al.
Cephalalgia : an International Journal of Headache|October 13, 2021
Effect of antibody switch in non-responders to a CGRP receptor antibody treatment in migraine: A multi-center retrospective cohort studyLucas Hendrik Overeem, Andreas Peikert, Maxi Dana Hofacker, et al.
Cerebrovascular Diseases Extra|September 21, 2013
Adapting the computed tomography criteria of hemorrhagic transformation to stroke magnetic resonance imagingLars Neeb, Kersten Villringer, Ivana Galinovic, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
The Journal of Headache and Pain|January 1, 2022
Deterioration of headache impact and health-related quality of life in migraine patients after cessation of preventive treatment with CGRP(-receptor) antibodiesMaria Terhart, Jasper Mecklenburg, Lars Neeb, et al.
Journal of Medical Internet Research|November 12, 2021
Patients' and Health Care Workers' Perception of Migraine Images on the Internet: Cross-sectional Survey StudyBianca Raffaelli, Pia Kull, Jasper Mecklenburg, et al.
The Journal of Headache and Pain|June 26, 2015
Two TRPV1 receptor antagonists are effective in two different experimental models of migraineJannis E Meents, Jan Hoffmann, Sandra R Chaplan, et al.
The Journal of Headache and Pain|June 23, 2021
Primary headaches during the COVID-19 lockdown in Germany: analysis of data from 2325 patients using an electronic headache diaryBianca Raffaelli, Jasper Mecklenburg, Simon Scholler, et al.
The Journal of Headache and Pain|March 30, 2022
Resumption of migraine preventive treatment with CGRP(-receptor) antibodies after a 3-month drug holiday: a real-world experienceBianca Raffaelli, Maria Terhart, Jasper Mecklenburg, et al.
Pain Medicine (Malden, Mass.)|March 7, 2023
Transcranial direct current stimulation to reduce chronic pelvic pain in endometriosis: phase II randomized controlled clinical trialSylvia Mechsner, Jackie Grünert, Jakob Johann Wiese, et al.
Schmerz (Berlin, Germany)|February 13, 2025
[The headache questionnaire of the German Migraine and Headache Society (DMKG) : A new tool to improve headache care]Ruth Ruscheweyh, Charly Gaul, Thomas Dresler, et al.
Schmerz (Berlin, Germany)|September 11, 2025
[Migraine patients treated with CGRP(R) antibodies : Are they different from patients treated with nonspecific oral prophylaxis? Analysis from the DMKG headache registry]Ruth Ruscheweyh, Gudrun Goßrau, Tim Patrick Jürgens, et al.
Cephalalgia : an International Journal of Headache|October 13, 2021
Effect of antibody switch in non-responders to a CGRP receptor antibody treatment in migraine: A multi-center retrospective cohort studyLucas Hendrik Overeem, Andreas Peikert, Maxi Dana Hofacker, et al.
Cerebrovascular Diseases Extra|September 21, 2013
Adapting the computed tomography criteria of hemorrhagic transformation to stroke magnetic resonance imagingLars Neeb, Kersten Villringer, Ivana Galinovic, et al.
Pageof 7